Medibank Private (MPL.AX) Aktie Kurs
Medibank Private Kurs
Omsætningen er vokset med 5,8 % om året de seneste 19 år til 9,33 Mrd. AUD. Indtjening pr. aktie er vokset med 8,1 % om året de seneste 13 år. Medibank Privates nettoavance ligger på 6,8 %, op fra 5,6 % for flere år siden. Medibank Private har i øjeblikket et direkteafkast på omkring 2,50 %. Udlodningsandelen er omkring 129 % af indtjeningen. Udbyttet er vokset med 4,2 % om året de seneste 11 år. Analytikernes mediankursmål er 5,00 AUD, hvilket er over den aktuelle kurs med 5,4 %. Af 14 analytikere anbefaler 5 køb — den samlede vurdering er Hold.
Medibank Private aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Medibank Private aktie og aktieanalyse
Hyppigt stillede spørgsmål om Medibank Private-aktien
Medibank Private Ltd operates as a leading private health insurance provider in Australia. The company's business model revolves around offering health insurance products and services to a wide range of individuals and families. Medibank Private aims to ensure accessibility, affordability, and quality healthcare for its customers. The company's model focuses on providing comprehensive coverage, including hospital treatment, specialist consultations, and ancillary services. By leveraging its extensive network of healthcare providers and utilizing advanced technological solutions, Medibank Private delivers value-based and customer-centric healthcare solutions. With a strong emphasis on innovation and customer satisfaction, Medibank Private continues to serve as a reliable and trusted health insurance partner.
Medibank Private Ltd is primarily active in the healthcare industry.
The main competitors of Medibank Private Ltd in the market include Bupa Australia, HCF, NIB Holdings Ltd, and HBF Health Limited.
Medibank Private Ltd is an Australian private health insurance company. It was established in 1976 as a government-owned entity to provide affordable health coverage to Australians. Initially, it operated as a not-for-profit organization until it was privatized in 2014 and listed on the Australian Securities Exchange (ASX). Since then, Medibank has evolved into a leading health insurer, offering a wide range of health insurance products and services to individuals, families, and businesses across Australia. With a strong focus on customer satisfaction and innovative healthcare solutions, Medibank Private Ltd continues to play a vital role in ensuring the well-being of millions of Australians.
Medibank Private Ltd, Australia's leading health insurer, has achieved several significant milestones throughout its history. One of the key achievements was its successful initial public offering (IPO) in 2014, marking its transition from a government-owned entity to a publicly listed company. Since then, Medibank has consistently delivered strong financial performance, demonstrating its commitment to shareholder value. The company has also expanded its services by introducing innovative healthcare programs and partnerships, aimed at improving the health and well-being of its members. Medibank's focus on customer satisfaction and high-quality healthcare has enabled it to become a trusted name in the industry, further reinforcing its position as a market leader.
Medibank Private Ltd is primarily present in Australia. This leading private health insurance provider operates predominantly in its home country, catering to a wide customer base. With its headquarters located in Melbourne, Medibank Private Ltd offers a range of health insurance services and products to individuals, families, and businesses across Australia.
Medibank Private Ltd represents a commitment to delivering high-quality healthcare services to its customers. The company values customer satisfaction and aims to provide accessible and affordable healthcare for all Australians. Medibank Private Ltd places importance on innovation, investing in new technologies and approaches to improve healthcare outcomes. With a focus on corporate responsibility, the company aims to make a positive impact on the health and wellbeing of individuals and communities. Medibank Private Ltd strives to be a trusted and customer-centric healthcare provider, ensuring the utmost care and support for its customers' health needs.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 5,22 AUD for Medibank Private-aktien (median: 5,00 AUD), svarende til +10,0 % i forhold til seneste kurs. Konsensus bygger på 14 analytikervurderinger.
14 analytikere vurderer i øjeblikket Medibank Private-aktien: 5 anbefaler køb, 9 hold og 0 salg.
Omregnet til den aktuelle valutakurs handles Medibank Private-aktien til 2,93 EUR (4,74 AUD).
Medibank Private-aktien (MPL.AX) er noteret på 5 børser, herunder: SIX (Zürich) (MPV.SW), ASX (MPL.AX), Frankfurt (MPV.F), München (MPV.MU), Düsseldorf (MPV.DU).
Medibank Private Ltd is a leading Australian health insurance company that provides its customers with high-quality health solutions and medical services. The company operates in four main areas: health insurance, health services, private hospitals, and life insurance. It offers a wide range of health insurance products and services, including individual and family plans, group plans for businesses, and a variety of health services such as home visits, telemedicine, and emergency services. The private hospital division provides access to top-notch facilities and medical services. The company also offers life insurance products and services, including life insurance, income protection insurance, and accident insurance. Medibank Private aims to improve the customer experience through innovative technologies and digital services, offering tools and applications to manage and improve health and lifestyle. Overall, Medibank Private has a strong business model focused on providing high-quality health solutions and medical services, with a strong market position and a commitment to expanding its product and service offerings to meet the changing needs of its customers.
-omsætningen for Medibank Private er 9,33 Mrd. AUD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
-overskuddet for Medibank Private er 638,70 Mio. AUD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Medibank Private er i øjeblikket 20,44. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Medibank Private-aktien.
Pris-til-salgs-forholdet (P/S) for Medibank Private er i øjeblikket 1,40. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Medibank Private-aktien.
AlleAktien-kvalitetsscore for Medibank Private er 5/10.
ISIN for Medibank Private er AU000000MPL3. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Medibank Private er A12D1W. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Medibank Private er MPL.AX. Tickersymbolet bruges til at handle Medibank Private-aktier på børsen.
Medibank Private aktie
Medibank Private Peer Group
Medibank Private Ticker
Medibank Private FIGI
Alle fundamentale data om Medibank Private i deep dive
Vores aktieanalyse af Medibank Private-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Medibank Private. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: